Pfizer Inc (NYSE: PFE) kicked off on Monday, down -1.36% from the previous trading day, before settling in for the closing price of $24.20. Over the past 52 weeks, PFE has traded in a range of $20.92-$31.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 17.19%. While this was happening, its average annual earnings per share was recorded -3.10%. With a float of $5.67 billion, this company’s outstanding shares have now reached $5.67 billion.
The extent of productivity of a business whose workforce counts for 81000 workers is very important to gauge. In terms of profitability, gross margin is 67.39%, operating margin of 21.03%, and the pretax margin is 11.83%.
Pfizer Inc (PFE) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Pfizer Inc is 0.04%, while institutional ownership is 67.80%. The most recent insider transaction that took place on May 05 ’25, was worth 1,312,736. Before that another transaction happened on Mar 04 ’25, when Company’s SVP & Controller sold 2,500 for $25.93, making the entire transaction worth $64,825. This insider now owns 11,850 shares in total.
Pfizer Inc (PFE) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -3.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.41% during the next five years compared to -13.25% drop over the previous five years of trading.
Pfizer Inc (NYSE: PFE) Trading Performance Indicators
Take a look at Pfizer Inc’s (PFE) current performance indicators. Last quarter, stock had a quick ratio of 0.92. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.17. Likewise, its price to free cash flow for the trailing twelve months is 13.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.38, a number that is poised to hit 0.56 in the next quarter and is forecasted to reach 3.09 in one year’s time.
Technical Analysis of Pfizer Inc (PFE)
The latest stats from [Pfizer Inc, PFE] show that its last 5-days average volume of 56.37 million was superior to 48.39 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 81.30%. Additionally, its Average True Range was 0.69.
During the past 100 days, Pfizer Inc’s (PFE) raw stochastic average was set at 44.40%, which indicates a significant decrease from 77.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 24.56% in the past 14 days, which was lower than the 25.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.56, while its 200-day Moving Average is $26.91. Now, the first resistance to watch is $24.13. This is followed by the second major resistance level at $24.39. The third major resistance level sits at $24.53. If the price goes on to break the first support level at $23.73, it is likely to go to the next support level at $23.59. The third support level lies at $23.33 if the price breaches the second support level.
Pfizer Inc (NYSE: PFE) Key Stats
The company with the Market Capitalisation of 135.38 billion has total of 5,671,455K Shares Outstanding. Its annual sales at the moment are 63,627 M in contrast with the sum of 8,031 M annual income. Company’s last quarter sales were recorded 17,763 M and last quarter income was 410,000 K.
